Document ID: chunk:federal_register_of_legislation:F2024L01037:clause:4_14
Version: federal_register_of_legislation:F2024L01037
Segment Type: clause
Provision Reference: sch 4 cl 14
Character Range: 12050–13555

14  Tests

Psilocybine extract products
 (1) Subject to subsection (2), for each item in the table in Part 1 of Schedule 2, a psilocybine extract product must comply with the requirements specified in column 4 using the test method specified in column 3, in relation to the test specified in column 2.
 (2) This section does not apply to an extemporaneously compounded psilocybine extract product where:
           (a) the psilocybine extract used in the manufacture of that product has been tested in accordance with the requirements specified in section 10 of this instrument; and
           (b) the testing was conducted at a site that is covered by a manufacturing licence granted by the Secretary under Part 3-3 of the Act.

Psilocybine isolate products
 (3) Subject to subsection (4), for each item in the table in Part 2 of Schedule 2, a psilocybine isolate product must comply with the requirements specified in column 4 using the test method specified in column 3, in relation to the test specified in column 2.
 (4) This section does not apply to an extemporaneously compounded psilocybine isolate product where:
           (a) the psilocybine isolate product used in the manufacture of that product has been tested in accordance with the requirements specified in section 10 of this instrument; and
           (b) the testing was conducted at a site that is covered by a manufacturing licence granted by the Secretary under Part 3-3 of the Act.

Part 4Requirements for synthetic psilocybine